Literature DB >> 8166183

Interleukin-1 in human ovarian cells and in peripheral blood monocytes increases during the luteal phase: evidence for a midcycle surge in the human.

M L Polan1, J A Loukides, J Honig.   

Abstract

OBJECTIVE: Resident ovarian macrophages are thought to be critically involved in cyclic ovarian events. A prominent macrophage product, interleukin-1, has been shown to affect ovarian cell function. In this report we present evidence for an intrafollicular periovulatory interleukin-1 surge. Additionally, we demonstrate that interleukin-1 beta messenger ribonucleic acid in peripheral blood monocytes increases threefold during the luteal phase of the menstrual cycle over that found in the follicular phase. STUDY
DESIGN: Follicular fluid cells isolated as a byproduct of transvaginal oocyte retrievals in gonadotropin-stimulated in vitro fertilization cycles were immunoprobed for the presence of interleukin-1 protein. Late follicular phase cumulus and granulosa cells obtained from an aspirated preovulatory follicle were likewise probed.
RESULTS: Although the in vitro fertilization-retrieved cells stained positive for interleukin-1 protein, the late follicular phase cells were devoid of the protein. Granulosa cells from in vitro fertilization cycles were examined for interleukin-1 protein binding sites with iodinated interleukin-1 alpha protein. These cells were found to have approximately 2000 binding sites per cell. Poly A+ messenger ribonucleic acid isolated from peripheral blood monocyte samples from women during the follicular and luteal phases and from male controls were probed for interleukin-1 ribonucleic acid content by means of Northern analysis. The luteal samples contained a threefold higher interleukin-1 messenger ribonucleic acid content that did the follicular phase samples or the controls.
CONCLUSION: The ovarian interleukin-1 protein increase taken together with increased peripheral blood monocyte interleukin-1 messenger ribonucleic acid suggests that interleukin-1 production increases at midcycle.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8166183     DOI: 10.1016/s0002-9378(94)70093-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  8 in total

Review 1.  Estrogen receptors in immunity and autoimmunity.

Authors:  Melissa Cunningham; Gary Gilkeson
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

2.  The midcycle increase in ovarian glucose uptake is associated with enhanced expression of glucose transporter 3. Possible role for interleukin-1, a putative intermediary in the ovulatory process.

Authors:  S Kol; I Ben-Shlomo; K Ruutiainen; M Ando; T M Davies-Hill; R M Rohan; I A Simpson; E Y Adashi
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

3.  Rat ovarian interleukin-1alpha: interleukin-1-dependent in vitro expression.

Authors:  S Kol; K H Wong; M Ando; I Ben-Shlomo; E Y Adashi
Journal:  Endocrine       Date:  1999-12       Impact factor: 3.633

4.  Giants in Obstetrics and Gynecology Series: a profile of Mary Lake Polan, PhD, MD, MPH.

Authors:  Roberto Romero
Journal:  Am J Obstet Gynecol       Date:  2022-02       Impact factor: 8.661

5.  Sexual activity modulates shifts in TH1/TH2 cytokine profile across the menstrual cycle: an observational study.

Authors:  Tierney K Lorenz; Julia R Heiman; Gregory E Demas
Journal:  Fertil Steril       Date:  2015-09-16       Impact factor: 7.329

6.  Sex Differences in monocytes and TLR4 associated immune responses; implications for systemic lupus erythematosus (SLE).

Authors:  Wei Jiang; Gary Gilkeson
Journal:  J Immunother Appl       Date:  2014-03-07

7.  Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells.

Authors:  S Ben-Eliyahu; G G Page; G Shakhar; A N Taylor
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

8.  Meta-analysis of associations of IL1 receptor antagonist and estrogen receptor gene polymorphisms with systemic lupus erythematosus susceptibility.

Authors:  Li Cai; Jin-wei Zhang; Xing-xin Xue; Zhi-gang Wang; Jia-jia Wang; Shai-di Tang; Shao-wen Tang; Jie Wang; Yun Zhang; Xian Xia
Journal:  PLoS One       Date:  2014-10-06       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.